These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 20682540)

  • 1. Extracorporeal membrane oxygenation support in management of severe respiratory failure secondary to 2009 influenza A(H1N1) virus.
    Yan TD; Poh CL; Martens-Nielsen J
    Chest; 2010 Aug; 138(2):455; author reply 455-6. PubMed ID: 20682540
    [No Abstract]   [Full Text] [Related]  

  • 2. Point: Efficacy of extracorporeal membrane oxygenation in 2009 influenza A(H1N1): sufficient evidence?
    Park PK; Dalton HJ; Bartlett RH
    Chest; 2010 Oct; 138(4):776-8. PubMed ID: 20923796
    [No Abstract]   [Full Text] [Related]  

  • 3. Counterpoint: Efficacy of extracorporeal membrane oxygenation in 2009 influenza A(H1N1): sufficient evidence?
    Morris AH; Hirshberg E; Miller RR; Statler KD; Hite RD
    Chest; 2010 Oct; 138(4):778-81; discussion 782-4. PubMed ID: 20923797
    [No Abstract]   [Full Text] [Related]  

  • 4. Novel pH1N1 viral cardiomyopathy requiring veno-venous extracorporeal membrane oxygenation.
    Subramanian S; Clark JD; Jeffries HE; McMullan DM
    Pediatr Crit Care Med; 2010 Nov; 11(6):714-7. PubMed ID: 20453697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracorporeal membrane oxygenation in pandemic flu: insufficient evidence or worth the effort?
    Dalton HJ; MacLaren G
    Crit Care Med; 2010 Jun; 38(6):1484-5. PubMed ID: 20502139
    [No Abstract]   [Full Text] [Related]  

  • 6. On high alert.
    Whyte A
    Nurs Stand; 2009 Nov 4-10; 24(9):20-1. PubMed ID: 19953761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of extracorporeal technology during pandemics: ethical and staffing considerations.
    Kissoon N; Bohn D
    Pediatr Crit Care Med; 2010 Nov; 11(6):757-8. PubMed ID: 21057269
    [No Abstract]   [Full Text] [Related]  

  • 8. A systematic review to inform institutional decisions about the use of extracorporeal membrane oxygenation during the H1N1 influenza pandemic.
    Mitchell MD; Mikkelsen ME; Umscheid CA; Lee I; Fuchs BD; Halpern SD
    Crit Care Med; 2010 Jun; 38(6):1398-404. PubMed ID: 20400902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The use of extracorporeal membrane oxygenation in sustaining pulmonary function patients with influenza A H1N1].
    Duan DW; Li T; Qin YZ; Xu L; Zhao CX; Hu XM; Wu P; Zhang Q; Lang YH
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2010 Mar; 22(3):161-3. PubMed ID: 20367907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracorporeal membrane oxygenation for pandemic H1N1 2009 respiratory failure.
    Holzgraefe B; Broomé M; Kalzén H; Konrad D; Palmér K; Frenckner B
    Minerva Anestesiol; 2010 Dec; 76(12):1043-51. PubMed ID: 21178913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracorporeal membrane oxygenation for 2009 influenza A(H1N1) severe respiratory failure in Japan.
    Takeda S; Kotani T; Nakagawa S; Ichiba S; Aokage T; Ochiai R; Taenaka N; Kawamae K; Nishimura M; Ujike Y; Tajimi K;
    J Anesth; 2012 Oct; 26(5):650-7. PubMed ID: 22618953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 'Rescue oxygenation therapies' for severe pH1N1-associated acute respiratory distress syndrome.
    Derdak S; Cannon JW
    Crit Care Med; 2010 Nov; 38(11):2257-8. PubMed ID: 20959754
    [No Abstract]   [Full Text] [Related]  

  • 13. A role for extracorporeal treatment in severe influenza?
    Burki NK
    South Med J; 2010 Aug; 103(8):727-8. PubMed ID: 20622735
    [No Abstract]   [Full Text] [Related]  

  • 14. Extracorporeal Life Support for severe respiratory failure with special reference to the influenza H1N1 pandemic.
    Holzgraefe B
    Acta Anaesthesiol Scand; 2017 Feb; 61(2):259-260. PubMed ID: 28066903
    [No Abstract]   [Full Text] [Related]  

  • 15. [ECMO for the patients with severe respiratory failure associated with ARDS due to influenza].
    Kobayashi K; Takeda S
    Masui; 2013 May; 62(5):557-62. PubMed ID: 23772529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are contraindications to extracorporeal membrane oxygenation slowly vanishing?
    Betit P
    Respir Care; 2011 Jul; 56(7):1054-5. PubMed ID: 21740731
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical features of a Dutch cohort of critically ill children due to the 2009 new influenza A H1N1 pandemic.
    van Zwol A; Witteveen R; Markhorst D; Geukers VG
    Clin Pediatr (Phila); 2011 Jan; 50(1):69-72. PubMed ID: 20837610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extra-corporeal membrane oxygenation in the management of 2009 influenza A (H1N1) refractory respiratory failure.
    Das JP; Chew N; Kitt E; Murphy C; O'Rourke J; Power M; McConkey SJ
    Ir Med J; 2011 Mar; 104(3):90-1. PubMed ID: 21667616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracorporeal membrane oxygenation in the context of the 2009 H1N1 influenza A pandemic.
    Sihler KC; Park PK
    Surg Infect (Larchmt); 2011 Apr; 12(2):151-8. PubMed ID: 21545282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxic therapy for severe swine flu A/H1N1.
    Henter JI; Palmkvist-Kaijser K; Holzgraefe B; Bryceson YT; Palmér K
    Lancet; 2010 Dec; 376(9758):2116. PubMed ID: 21168053
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.